Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
AVI BioPharma Joining Russell 3000 Index
AVI BioPharma, 06/29/09
AVI BioPharma, Inc. , a developer of RNA-based drugs, announced that immediately following the close of the U.S. markets it will join the broad-market Russell 3000 Index following Russell Investments' annual reconstitution of its comprehensive set of U.S. and global equity indexes.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
EMEA recommends authorization of swine flu vaccines
Pharmaceutical Technology, 10/14/09
Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09
Article Search
Sponsor